Science Corp.
Science is a clinical stage, vertically integrated technology company focused on solving some of neuroscience’s hardest questions and most serious unmet medical needs.
CORE INFO
Science Corporation is a clinical-stage medical technology company developing advanced devices to restore vision, cognition, and mobility for individuals with severe neurological and sensory impairments. Their flagship product, PRIMA, is a retinal implant aimed at restoring vision in patients with advanced macular degeneration.
- Science Corporation raised $230 million in a Series C funding round in March 2026, valuing the company at $1.5 billion post-money.techcrunch.com
- TechCrunch reported on Science Corporation's efforts to commercialize the PRIMA retinal implant following their latest funding round.techcrunch.com
- In trials, 80% of patients demonstrated meaningful improvement in visual acuity, being able to read letters, numbers, and words.techcrunch.com
WHY WE WOULD WORK AT SCIENCE CORPORATION
Transform Lives
Join a mission-driven team dedicated to restoring vision, cognition, and mobility for individuals suffering from debilitating conditions. Your work will directly impact patients' lives through groundbreaking technologies like the PRIMA retinal implant.
Innovative Technology
Be part of a pioneering company specializing in brain-computer interfaces and neural engineering. Work with cutting-edge advancements that transcend biological limits to enhance human well-being.
Rapid Growth
Science Corp. has raised $490 million in funding, including a recent $230 million Series C round, positioning the company for significant expansion and innovation in the medical technology field.
Recognized Leadership
Work alongside industry leaders like Max Hodak, named to Time's 100 Health List, and contribute to a company recognized for its pioneering advancements in medical technology.
Collaborative Culture
Join a diverse team of over 150 passionate professionals who prioritize ethical standards and a patient-first approach in their work. Collaborate in a supportive environment that fosters innovation and creativity.
Cutting-Edge Research
Engage in groundbreaking research and development of technologies like biohybrid neural interfaces and organ preservation under the Vessel initiative, pushing the boundaries of what's possible in medicine.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
GROWTH TACTICS
KEY METRICS
✦ KEY METRICMARKET POSITION
NOTABLE ACHIEVEMENTS
✦ KEY METRICPRODUCT AND TECH
PRIMA Retinal Implant
The PRIMA retinal implant is Science Corporation's flagship product designed to restore functional vision in patients with advanced macular degeneration. This innovative device represents a significant advancement in treating vision loss where traditional options are ineffective.
Biohybrid Neural Interfaces
Science Corporation is developing biohybrid neural interfaces that integrate biological and artificial components to enhance communication between the brain and external devices. This technology aims to improve cognitive function and mobility for individuals with neurological impairments.
Organ Preservation Technologies
Under the Vessel initiative, Science Corporation is focused on developing advanced organ preservation technologies that aim to extend the viability of organs for transplantation. This innovation is crucial for improving transplant outcomes and addressing organ shortages.
Brain-Computer Interface (BCI) Technology
The company specializes in brain-computer interface technology, which allows direct communication between the brain and external devices. This technology has the potential to revolutionize treatment options for patients with severe neurological conditions.
Microelectromechanical Systems (MEMS)
Science Corporation utilizes microelectromechanical systems (MEMS) in its medical applications, enabling the development of miniaturized devices that can interact with biological systems. MEMS technology is essential for creating precise and effective medical devices.